SYDNEY BRENNER Salk Institute, 100010 N

Total Page:16

File Type:pdf, Size:1020Kb

SYDNEY BRENNER Salk Institute, 100010 N NATURE’S GIFT TO SCIENCE Nobel Lecture, December 8, 2002 by SYDNEY BRENNER Salk Institute, 100010 N. Torrey Pines Road, La Jolla, California, USA, and King’s College, Cambridge, England. The title of my lecture is “Nature’s gift to Science.” It is not a lecture about one scientific journal paying respects to another, but about how the great di- versity of the living world can both inspire and serve innovation in biological research. Current ideas of the uses of Model Organisms spring from the ex- emplars of the past and choosing the right organism for one’s research is as important as finding the right problems to work on. In all of my research these two decisions have been closely intertwined. Without doubt the fourth winner of the Nobel prize this year is Caenohabditis elegans; it deserves all of the honour but, of course, it will not be able to share the monetary award. I intend to tell you a little about the early work on the nematode to put it into an intellectual perspective. It bridges, both in time and concept, the biol- ogy we practice today and the biology that was initiated some fifty years ago with the revolutionary discovery of the double-helical structure of DNA by Watson and Crick. My colleagues who follow will tell you more about the worm and also recount their incisive research on the cell lineage and on the genetic control of all death. To begin with, I can do no better than to quote from the paper I published in 1974 (1). The paper was unhesitatingly entitled: “The genetics of Caenor- habditis elegans” and the opening sentence reads: “How genes might specify the complex structures found in higher organisms is a major unsolved prob- lem of biology.” This is still true today. The paper outlined how a genetic ap- proach coupled with detailed studies at the cellular level might be a way of studying this important question. It introduced C. elegans as the organism of choice for this work. This choice had a long history. Twenty years earlier, we had posed a differ- ent question. Then, the central problem in biology was how the one-dimen- sional sequence of nucleotides in DNA specified the one-dimensional se- quence of amino acids in proteins. Today, any student would give this question a very simple answer. ‘All you have to do is to find a gene and have it sequenced and then make some protein using the gene and get someone to determine its amino acid sequence.’ In those early days, the techniques for determining amino acid sequences of proteins were primitive and needed large amounts of proteins which had to be purified first. There were no 274 methods to isolate genes and no techniques for the chemical determination of their sequences. Our analysis of genes was limited to genetics. Indeed, the only way we could assert that there was a gene in an organism was by finding a mutant allele for it. Like Mendel, we could not say that there was a gene for the character of tallness until dwarf mutants were discovered suffering from a heritable lack of tallness. Genetic analysis of linkage used recombination to analyse the structure of chromosomes, to determine the locations of genes and their linear order along a chromosome. But in order to probe the struc- ture of the gene something special was needed. That was provided by bacte- riophages, viruses with tiny genomes which grew on bacteria and which showed recombination. In 1954, Seymour Benzer developed a system using the rII gene of bacteriophage T4, in which powerful selection could be ex- erted for the r+ phenotype. Forward mutants could be easily picked and large numbers of phage crosses could be readily performed. The selection method allowed recombinants to be measured at very high resolution, limited only by the rates of reverse mutations. These experiments revealed that the gene con- tained hundreds of sites at which mutation could occur and that the scale of separation was of the order of the distances between adjacent base pairs on the DNA structure. The experiments not only exploded the classical idea of the gene as an indivisible unit of function, mutation and recombination, but the fine structure map could now be viewed as a picture of the nucleotide se- quence of the DNA. It therefore provided an approach to studying how the sequence of bases in DNA might correspond to the sequence of amino acids in proteins by using genetics for the first and chemistry for the latter. This programme of molecular genetics was never quite completed, but the ex- ploitation of the properties of T4 bacteriophages played important roles in studies of mutagenesis, the general nature of the genetic code and genetic suppression, and in the demonstration of the existence of messenger RNA. For our purposes today we need to reflect on the properties that made phages that ideal ‘model organisms’ for this phase of research in molecular biology. They were easy to grow and maintain in a laboratory, large numbers could be readily generated, and many experiments could be conducted in parallel. The final readout was the presence or absence of lysis of bacteria and this assay could be applied to single particles each of which left a plaque – an area of lysis in a lawn of bacteria. For mapping purposes, scoring was digital – yes or no – and single particles could be easily counted to obtain accurate fre- quencies. After the basic principles of information transfer from genes to proteins had been established with the identification of messenger RNA, the discovery of the mechanism of protein synthesis and the structure of genetic code, it was natural for some of us to ask whether the lessons learnt in molecular biol- ogy could be applied to the genetics of more complex phenotypes. All ques- tions in genetics involve asking how the phenotype is represented in the genotype or, reflexively, how the genes map onto the phenotype. It was clear that one could not have understood how metabolism or biosynthesis was rep- resented on the genome until one had conceived of the ‘one gene-one en- 275 zyme relationship’, that a gene specified the amino acid sequence of a polypeptide chain, which after folding correctly, was able to perform a spe- cific catalytic function in a metabolic pathway. In the same way, the elaborate structure of the protein coat of a bacteriophage could not be understood without knowing that it was built of many different kinds of subunits and that these were able to self-assembly into the final particle. We have to know how the gene specifies the construction of the entity which carries out the func- tion. The same is true at a higher level of organization. In studying the ge- netics of behaviour, it is difficult, if not impossible, to go directly from the gene to behaviour, because there is no simple mapping that connects the two. In my paper, I put it in this way: “Behaviour is the result of a complex ill-un- derstood set of computations performed by nervous systems and it seems es- sential to decompose the question into two: one concerned with the question of the genetic specification of nervous systems and the other with the way ner- vous systems work to produce behaviour.” Thus, just as the structure and function of protein molecules is the necessary connection between the genes and metabolism, the link between genes and behaviour resides in under- standing the structure of nervous systems and how they are constructed. These are questions of anatomy and embryological development. This set the requirements for the experimental organism as one which was not only suit- able for genetical study in the laboratory but also allowed the structure of the nervous system to be accurately defined. Since a nervous system is essentially a cellular network, we had to be able to observe junctions between cells and their processes and this could only be achieved with the electron microscope which has the necessary resolution. Since the electron microscope provides only a small window because of its high magnification, we needed a small ani- mal which would also need to have a nervous system with a small number of cells. After some searching, my choice finally settled on the small nematode, Caenorhabditis elegans. This was a self-fertilizing hermaphrodite with rare spon- taneous males. The adults are about 1 mm in length and the life cycle is com- 1 pleted in 3 /2 days. The animals live in a two-dimensional world feeding on E. coli on the surface of agar plates. They are easy to grow in bulk, each ani- mal producing about 300 progeny during a cycle. My paper reported the iso- lation of several hundred mutants together their complementation and map- ping to define about one hundred loci. In parallel with the genetic work, I launched a program with Nichol Thompson to determine the complete struc- ture of the worm by serial section electron microscopy (2). This project was completed by John White and Eileen Southgate who joined the group soon af- ter it started and whose work resulted in the determination of the complete structure of the nervous system (and much more besides) in C.elegans (3). The paper I referred to summarized the work on genetics but, in the early seventies, trying to understand the functions of genes specifying the develop- ment of the nervous system in molecular terms seemed impossibly remote. However, going to the molecular level was inevitable, and we very early initi- ated studies of mutants which affected the movement of the worm by disrupting muscle structure function (4,5,6).
Recommended publications
  • | Sydney Brenner |
    | SYDNEY BRENNER | TOP THREE AWARDS • Nobel Prize in Physiology, 2002 • Albert Lasker Special Achievement Award, 2000 • National Order of Mapungubwe (Gold), 2004 DEFINING MOMENT To view the DNA model for the first time. 32 |LEGENDS OF SOUTH AFRICAN SCIENCE| A LIFE DEDICATED TO SCIENCE C. ELEGANS WORK In the more than eight decades that Nobel Laureate, Prof Sydney Brenner, “To start with we propose to identify every cell in the worm and trace line- has all-consumingly devoted his life to science, he twice wrote powerful age. We shall also investigate the constancy of development and study proposals of no longer than a page. Short but sweet, these kick-started the its control by looking for mutants,” is how Brenner ended his proposal on two projects that are part of his lasting legacy. Caenorhabditis elegans to the UK Medical Research Council in October 1963. He was looking for a new challenge after already having helped to The first was to request funding to study a worm, because he saw in the show that genetic code is composed of non-overlapping triplets and that nematode Caenorhabditis elegans the ideal genetic model organism. messenger ribonucleic acid (mRNA) exists. He was right, and received the Nobel Prize for his efforts. The other pro- posal, which set out how Singapore could become a hub for biomedical His first paper on C. elegans appeared in Genetics in 1974, and in all, the research, earned him the title of “mentor to a nation’s science ambitions”. work took about 20 years to reach its full potential.
    [Show full text]
  • Ethical Principles in Ethical Principles in Scientific Research Scientific Research and Publications
    Hacettepe University Institute of Oncology Library ETHICAL PRINCIPLES IN SCIENTIFIC LectureRESEARCH author AND PUBLICATIONSOnlineby © Emin Kansu,M.D.,FACP ESCMID ekansu@ada. net. tr Library Lecture author Onlineby © ESCMID HACETTEPE UNIVERSITY MEDICAL CENTER Library Lecture author Onlineby © ESCMID INSTITUTE OF ONCOLOGY - HACETTEPE UNIVERSITY Ankara PRESENTATION • UNIVERSITY and RESEARCHLibrary • ETHICS – DEFINITION • RESEARCH ETHICS • PUBLICATIONLecture ETHICS • SCIENTIFIC MISCONDUCTauthor • SCIENTIFIC FRAUD AND TYPES Onlineby • HOW TO PREVENT© UNETHICAL ISSUES • WHAT TO DO FOR SCIENTIFIC ESCMIDMISCONDUCTS Library Lecture author Onlineby © ESCMID IMPACT OF TURKISH SCIENTISTS 85 % University – Based 1.78% 0.2 % 19. 300 18th ‘ACADEMIA’ UNIVERSITY Library AN INSTITUTION PRODUCING and DISSEMINATING SCIENCE Lecture BASIC FUNCTIONS author Online-- EDUCATIONby © -- RESEARCH ESCMID - SERVICESERVICE UNIVERSITY Library • HAS TO BE OBJECTIVE • HAS TO BE HONESTLecture AND ETHICAL • HAS TO PERFORM THEauthor “STATE-OF-THE ART” • HAS TO PLAYOnline THEby “ROLE MODEL” , TO BE GENUINE AND ©DISCOVER THE “NEW” • HAS TO COMMUNICATE FREELY AND HONESTLY WITH ALL THE PARTIES INVOLVED IN ESCMIDPUBLIC WHY WE DO RESEARCH ? Library PRIMARY AIM - ORIGINAL CONTRIBUTIONS TO SCIENCE Lecture SECONDARY AIM author - TOOnline PRODUCEby A PAPER - ACADEMIC© PROMOTION - TO OBTAIN AN OUTSIDE SUPPORT ESCMID SCIENTIFIC RESEARCH Library A Practice aimed to contribute to knowledge or theoryLecture , performed in disciplined methodologyauthor and Onlineby systematic approach©
    [Show full text]
  • Sborník Konferenčních Příspěvků Byl Vydán Pod ISBN 978-80-7305-117-4 a Poskytnut Všem 170 Registrovaným Účastníkům Konference
    111 let Nobelových cen MENDEL FORUM 2011 Projekt „Od fyziologie k medicíně“ CZ.1.07/2.3.00/09.0219, který je prezentován v rámci konference Mendel Forum 2011, je spolufinancován Evropským sociálním fondem a státním rozpočtem České republiky. Mendelianum MZM, Brno Ústav fyziologie FVL VFU Brno ÚŽFG AV ČR, v.v.i., Brno ISBN 978-80-7305-132-7 MENDEL FORUM 2011 25. - 26. října 2011 Dietrichsteinský palác Zelný trh, Brno PROGRAM úterý 25. října 2011 8:30 – 9:00 registrace, zahájení Sekce: OD FYZIOLOGIE K MEDICÍNĚ 9:00 – 9:30 Od fyziologie k medicíně: vzdělávací projekty (I. Fellnerová) 9:30 – 10:00 Fyziologie/medicína v Nobelových cenách (J. Doubek) Sekce: GENETIKA-MENDEL 9:30 – 10:00 Mendel Memorial Medal Mendel Lecture (S. Zadražil) 10:30 – 11:00 diskuse, přestávka s občerstvením 2 11:00 - 11:30 Mendel – neustálá výzva (J. Sekerák) 11:30 – 12:00 Mendel, Biskupský dvůr a počátky vědy na Moravě (J. Mitáček) s navazující odpolední prohlídkou Biskupského dvora středa 26. října 2011 Sekce: NOBELOVY CENY 21. STOLETÍ 9:00 – 9:30 Nobelovy ceny v novém tisícíletí (E. Matalová) 9:30 – 10:00 Helicobacter pylori (M. Heroldová) 10:00 – 10:30 Umlčování genů (M. Buchtová) 10:30 – 11:00 přestávka 3 11:00 – 11:30 Telomery a nesmrtelnost (L. Dubská) 11:30 – 12:00 In vitro fertilizace (B. Kuřecová) s navazující diskusí a občerstvením ************************************** 111 let Nobelových cen http://nobelprize.org/nobel_prizes/about/ 4 Seznam přednášejících, kontakty doc. RNDr. Marcela Buchtová, Ph.D Ústav živočišné fyziologie a genetiky AV ČR, v.v.i., Brno, Fakulta veterinárního lékařství, VFU Brno [email protected], www.iapg.cas.cz prof.
    [Show full text]
  • Annual Report Fy 2018 Human Frontier Science Program Organization
    APRIL 2017 APRIL 2018 — MARCH 2019 ANNUAL REPORT FY 2018 HUMAN FRONTIER SCIENCE PROGRAM ORGANIZATION The Human Frontier Science Program Organization (HFSPO) is unique, supporting international collaboration to undertake innovative, risky, basic research at the frontier of the life sciences. Special emphasis is given to the support and training of independent young investigators, beginning at the postdoctoral level. The Program is implemented by an international organisation, supported financially by Australia, Canada, France, Germany, India, Italy, Japan, the Republic of Korea, New Zealand, Norway, Singapore, Switzerland, the United Kingdom of Great Britain and Nothern Ireland, the United States of America, and the European Commission. Since 1990, over 7000 researchers from more than 70 countries have been supported. Of these, 28 HFSP awardees have gone on to receive the Nobel Prize. 2 The following documents are available on the HFSP website www.hfsp.org: Joint Communiqués (Tokyo 1992, Washington 1997, Berlin 2002, Bern 2004, Ottawa 2007, Canberra 2010, Brussels 2013, London 2016): https://www.hfsp.org/about/governance/membership Statutes of the International Human Frontier Science Program Organization: https://www.hfsp.org/about/governance/hfspo-statutes Guidelines for the participation of new members in HFSPO: https://www.hfsp.org/about/governance/membership General reviews of the HFSP (1996, 2001, 2006-2007, 2010, 2018): https://www.hfsp.org/about/strategy/reviews Updated and previous lists of awards, including titles and abstracts:
    [Show full text]
  • Cambridge's 92 Nobel Prize Winners Part 4 - 1996 to 2015: from Stem Cell Breakthrough to IVF
    Cambridge's 92 Nobel Prize winners part 4 - 1996 to 2015: from stem cell breakthrough to IVF By Cambridge News | Posted: February 01, 2016 Some of Cambridge's most recent Nobel winners Over the last four weeks the News has been rounding up all of Cambridge's 92 Nobel Laureates, which this week comes right up to the present day. From the early giants of physics like JJ Thomson and Ernest Rutherford to the modern-day biochemists unlocking the secrets of our genome, we've covered the length and breadth of scientific discovery, as well as hugely influential figures in economics, literature and politics. What has stood out is the importance of collaboration; while outstanding individuals have always shone, Cambridge has consistently achieved where experts have come together to bounce their ideas off each other. Key figures like Max Perutz, Alan Hodgkin and Fred Sanger have not only won their own Nobels, but are regularly cited by future winners as their inspiration, as their students went on to push at the boundaries they established. In the final part of our feature we cover the last 20 years, when Cambridge has won an average of a Nobel Prize a year, and shows no sign of slowing down, with ground-breaking research still taking place in our midst today. The Gender Pay Gap Sale! Shop Online to get 13.9% off From 8 - 11 March, get 13.9% off 1,000s of items, it highlights the pay gap between men & women in the UK. Shop the Gender Pay Gap Sale – now. Promoted by Oxfam 1.1996 James Mirrlees, Trinity College: Prize in Economics, for studying behaviour in the absence of complete information As a schoolboy in Galloway, Scotland, Mirrlees was in line for a Cambridge scholarship, but was forced to change his plans when on the weekend of his interview he was rushed to hospital with peritonitis.
    [Show full text]
  • ILAE Historical Wall02.Indd 10 6/12/09 12:04:44 PM
    2000–2009 2001 2002 2003 2005 2006 2007 2008 Tim Hunt Robert Horvitz Sir Peter Mansfi eld Barry Marshall Craig Mello Oliver Smithies Luc Montagnier 2000 2000 2001 2002 2004 2005 2007 2008 Arvid Carlsson Eric Kandel Sir Paul Nurse John Sulston Richard Axel Robin Warren Mario Capecchi Harald zur Hauser Nobel Prizes 2000000 2001001 2002002 2003003 200404 2006006 2007007 2008008 Paul Greengard Leland Hartwell Sydney Brenner Paul Lauterbur Linda Buck Andrew Fire Sir Martin Evans Françoise Barré-Sinoussi in Medicine and Physiology 2000 1st Congress of the Latin American Region – in Santiago 2005 ILAE archives moved to Zurich to become publicly available 2000 Zonismide licensed for epilepsy in the US and indexed 2001 Epilepsia changes publishers – to Blackwell 2005 26th International Epilepsy Congress – 2001 Epilepsia introduces on–line submission and reviewing in Paris with 5060 delegates 2001 24th International Epilepsy Congress – in Buenos Aires 2005 Bangladesh, China, Costa Rica, Cyprus, Kazakhstan, Nicaragua, Pakistan, 2001 Launch of phase 2 of the Global Campaign Against Epilepsy Singapore and the United Arab Emirates join the ILAE in Geneva 2005 Epilepsy Atlas published under the auspices of the Global 2001 Albania, Armenia, Arzerbaijan, Estonia, Honduras, Jamaica, Campaign Against Epilepsy Kyrgyzstan, Iraq, Lebanon, Malta, Malaysia, Nepal , Paraguay, Philippines, Qatar, Senegal, Syria, South Korea and Zimbabwe 2006 1st regional vice–president is elected – from the Asian and join the ILAE, making a total of 81 chapters Oceanian Region
    [Show full text]
  • Human Genetics 1990–2009
    Portfolio Review Human Genetics 1990–2009 June 2010 Acknowledgements The Wellcome Trust would like to thank the many people who generously gave up their time to participate in this review. The project was led by Liz Allen, Michael Dunn and Claire Vaughan. Key input and support was provided by Dave Carr, Kevin Dolby, Audrey Duncanson, Katherine Littler, Suzi Morris, Annie Sanderson and Jo Scott (landscaping analysis), and Lois Reynolds and Tilli Tansey (Wellcome Trust Expert Group). We also would like to thank David Lynn for his ongoing support to the review. The views expressed in this report are those of the Wellcome Trust project team – drawing on the evidence compiled during the review. We are indebted to the independent Expert Group, who were pivotal in providing the assessments of the Wellcome Trust’s role in supporting human genetics and have informed ‘our’ speculations for the future. Finally, we would like to thank Professor Francis Collins, who provided valuable input to the development of the timelines. The Wellcome Trust is a charity registered in England and Wales, no. 210183. Contents Acknowledgements 2 Overview and key findings 4 Landmarks in human genetics 6 1. Introduction and background 8 2. Human genetics research: the global research landscape 9 2.1 Human genetics publication output: 1989–2008 10 3. Looking back: the Wellcome Trust and human genetics 14 3.1 Building research capacity and infrastructure 14 3.1.1 Wellcome Trust Sanger Institute (WTSI) 15 3.1.2 Wellcome Trust Centre for Human Genetics 15 3.1.3 Collaborations, consortia and partnerships 16 3.1.4 Research resources and data 16 3.2 Advancing knowledge and making discoveries 17 3.3 Advancing knowledge and making discoveries: within the field of human genetics 18 3.4 Advancing knowledge and making discoveries: beyond the field of human genetics – ‘ripple’ effects 19 Case studies 22 4.
    [Show full text]
  • John Sulston 1942-2018 Book of Celebration I Was Privileged to Work in the Same Lab As John at the Sanger Cenre in the 1990S
    John Sulston 1942-2018 Book of celebration I was privileged to work in the same lab as John at the Sanger Cenre in the 1990s. I found John to be an inspirational man. He was incredibly kind and a pleasure to speak with. He always made me feel valued. I have a very fond memory of showing some colleagues at the time the results that can be produced with dry ice and soap to create a ‘snake of foam’ (admittedly, not work related) - when John’s voice came close behind me - ‘are you having fun Emma?’ Some years after leaving the Sanger Centre, I bumped into John at a pub. He asked me if I was still having fun. I first met John Sulston in 2002 when Decades later, I have often thought of contacting John to express my thanks. My health has not been perfect The Common Thread was published. and I have to take Biologics to be able to move. Because of John’s work - drugs like this have been quicker in He had lunch with a bunch of us PhD students the making and available on the NHS. Thanks to John - I am still having fun. during the Edinburgh Book Festival. I was in It amazes me to think of all the people like me, who have been and will be helped by John’s work - now and awe, but he was so friendly, down-to-earth for all time. In addition, he was such a decent and respectful person. I am sure will be greatly missed by all and appeared to be entirely without ego.
    [Show full text]
  • Lasker Interactive Research Nom'18.Indd
    THE 2018 LASKER MEDICAL RESEARCH AWARDS Nomination Packet albert and mary lasker foundation November 1, 2017 Greetings: On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination for the 2018 Lasker Medical Research Awards. Since 1945, the Lasker Awards have recognized the contributions of scientists, physicians, and public citizens who have made major advances in the understanding, diagnosis, treatment, cure, and prevention of disease. The Medical Research Awards will be offered in three categories in 2018: Basic Research, Clinical Research, and Special Achievement. The Lasker Foundation seeks nominations of outstanding scientists; nominations of women and minorities are encouraged. Nominations that have been made in previous years are not automatically reconsidered. Please see the Nomination Requirements section of this booklet for instructions on updating and resubmitting a nomination. The Foundation accepts electronic submissions. For information on submitting an electronic nomination, please visit www.laskerfoundation.org. Lasker Awards often presage future recognition of the Nobel committee, and they have become known popularly as “America’s Nobels.” Eighty-seven Lasker laureates have received the Nobel Prize, including 40 in the last three decades. Additional information on the Awards Program and on Lasker laureates can be found on our website, www.laskerfoundation.org. A distinguished panel of jurors will select the scientists to be honored with Lasker Medical Research Awards. The 2018 Awards will
    [Show full text]
  • Close to the Edge: Co-Authorship Proximity of Nobel Laureates in Physiology Or Medicine, 1991 - 2010, to Cross-Disciplinary Brokers
    Close to the edge: Co-authorship proximity of Nobel laureates in Physiology or Medicine, 1991 - 2010, to cross-disciplinary brokers Chris Fields 528 Zinnia Court Sonoma, CA 95476 USA fi[email protected] January 2, 2015 Abstract Between 1991 and 2010, 45 scientists were honored with Nobel prizes in Physiology or Medicine. It is shown that these 45 Nobel laureates are separated, on average, by at most 2.8 co-authorship steps from at least one cross-disciplinary broker, defined as a researcher who has published co-authored papers both in some biomedical discipline and in some non-biomedical discipline. If Nobel laureates in Physiology or Medicine and their immediate collaborators can be regarded as forming the intuitive “center” of the biomedical sciences, then at least for this 20-year sample of Nobel laureates, the center of the biomedical sciences within the co-authorship graph of all of the sciences is closer to the edges of multiple non-biomedical disciplines than typical biomedical researchers are to each other. Keywords: Biomedicine; Co-authorship graphs; Cross-disciplinary brokerage; Graph cen- trality; Preferential attachment Running head: Proximity of Nobel laureates to cross-disciplinary brokers 1 1 Introduction It is intuitively tempting to visualize scientific disciplines as spheres, with highly produc- tive, well-funded intellectual and political leaders such as Nobel laureates occupying their centers and less productive, less well-funded researchers being increasingly peripheral. As preferential attachment mechanisms as well as the economics of employment tend to give the well-known and well-funded more collaborators than the less well-known and less well- funded (e.g.
    [Show full text]
  • Advertising (PDF)
    Share the wonders of the brain and mind with A PUBLIC INFORMATION INITIATIVE OF: Seeking resources to communicate with the public about neuroscience? Educating others through Brain Awareness activities? BrainFacts.org can help you communicate how the brain works. Explore BrainFacts.org for easy-to-use, accessible resources including: s Information about hundreds of diseases and disorders s Concepts about brain function s Educational tools s Multimedia tools and a social media community s Interviews and discussions with leading researchers; and more Visit BrainFacts.org Give to the Friends of SfN Fund Join us in forging the future of neuroscience Support a future of discovery and progress through travel awards and public education and outreach programs. To inquire about specific initiatives or to make a tax-deductible contribution, visit SfN.org or email: [email protected]. THE HISTORY OF NEUROSCIENCE IN AUTOBIOGRAPHY THE LIVES AND DISCOVERIES OF EMINENT SENIOR NEUROSCIENTISTS CAPTURED IN AUTOBIOGRAPHICAL BOOKS AND VIDEOS The History of Neuroscience in Autobiography Series Edited by Larry R. Squire Outstanding neuroscientists tell the stories of their scientific work in this fascinating series of autobiographical essays. Within their writings, they discuss major events that shaped their discoveries and their influences, as well as people who inspired them and helped shape their careers as neuroscientists. The History of Neuroscience in Autobiography, Vol. 1 The History of Neuroscience in Autobiography, Vol. 4 Denise Albe-Fessard, Julius Axelrod, Peter O. Bishop, Per Andersen, Mary Bunge, Jan Bures, Jean-Pierre Changeux, Theodore H. Bullock, Irving T. Diamond, Robert Galambos, John Dowling, Oleh Hornykiewicz, Andrew Huxley, Jac Sue Viktor Hamburger, Sir Alan L.
    [Show full text]
  • An Error Detection and Correction Framework for Connectomics
    An Error Detection and Correction Framework for Connectomics Jonathan Zung Ignacio Tartavull∗ Kisuk Leey Princeton University Princeton University MIT [email protected] [email protected] [email protected] H. Sebastian Seung Princeton University [email protected] Abstract We define and study error detection and correction tasks that are useful for 3D reconstruction of neurons from electron microscopic imagery, and for image seg- mentation more generally. Both tasks take as input the raw image and a binary mask representing a candidate object. For the error detection task, the desired output is a map of split and merge errors in the object. For the error correction task, the desired output is the true object. We call this object mask pruning, because the candidate object mask is assumed to be a superset of the true object. We train multiscale 3D convolutional networks to perform both tasks. We find that the error-detecting net can achieve high accuracy. The accuracy of the error-correcting net is enhanced if its input object mask is “advice” (union of erroneous objects) from the error-detecting net. 1 Introduction While neuronal circuits can be reconstructed from volumetric electron microscopic imagery, the process has historically [39] and even recently [37] been highly laborious. One of the most time- consuming reconstruction tasks is the tracing of the brain’s “wires,” or neuronal branches. This task is an example of instance segmentation, and can be automated through computer detection of the boundaries between neurons. Convolutional networks were first applied to neuronal boundary detection a decade ago [14, 38]. Since then convolutional nets have become the standard approach, arXiv:1708.02599v2 [cs.CV] 3 Dec 2017 and the accuracy of boundary detection has become impressively high [40, 3, 21, 9].
    [Show full text]